Epizyme Announces Extension of Celgene Research Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Epizyme (EPZM) Revised Celgene Agreement 'Net Positive', Mizuho Securities Says
July 9, 2015 10:15 AM EDTMizuho Securities analyst Peter Lawson said Epizyme's (NASDAQ: EPZM) amended agreement with Celgene (NASDAQ: CELG) is hard to compare to the prior one, but overall they view it as a positive.
Lawson cited: 1) CELG's interest continues - the... More
